Načítá se...
Novel Antigens for RSV Vaccines
Respiratory syncytial virus (RSV) remains a leading global cause of infant mortality and adult morbidity. Infection, which recurs throughout life, elicits only short-lived immunity. The development of a safe and efficacious vaccine has, thus far, been elusive. Recent technological advances, however,...
Uloženo v:
| Vydáno v: | Curr Opin Immunol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4553118/ https://ncbi.nlm.nih.gov/pubmed/26070108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2015.04.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|